Pressure Continues for TPP to Include Biologic Exclusivity
As the Trans-Pacific Partnership (TPP) talks head into their 14th round early next month, U.S. lawmakers continue to press the president to ensure the negotiations protect the 12-year data exclusivity for biologics.
Such protection is needed for U.S. biotechs to compete on a level playing field and to safeguard the health of the nation's life sciences industry, Sen. Claire McCaskill (D-Mo.) said in a recent letter to the president.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST